Related Experiment Video

Updated: Jun 5, 2026

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

Facilitation of μ-opioid receptor activity by preventing δ-opioid receptor-mediated codegradation

Shao-Qiu He1, Zhen-Ning Zhang, Ji-Song Guan

  • 1Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, People's Republic of China.

Neuron
|January 12, 2011
PubMed

Insights

Dissociating delta-opioid receptors (DORs) from mu-opioid receptors (MORs) prevents MOR degradation, enhancing morphine

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Delta-opioid receptors (DORs) form heteromers with mu-opioid receptors (MORs).
  • DORs negatively regulate MOR-mediated spinal analgesia through unclear mechanisms.
  • Understanding MOR/DOR interactions is crucial for improving opioid therapies.

Purpose of the Study:

  • To elucidate the mechanism by which DORs regulate MOR activity.
  • To investigate strategies for enhancing MOR-mediated analgesia and reducing tolerance.
  • To explore the therapeutic potential of disrupting MOR/DOR interactions.

Main Methods:

  • Treatment with DOR-specific agonists and an interfering peptide (MOR(TM1)).
  • Analysis of receptor endocytosis, ubiquitination, and lysosomal degradation.
  • In vivo studies in mice using a MOR(TM1)-TAT fusion protein.

Main Results:

  • DOR activation promotes MOR/DOR heteromer endocytosis and subsequent lysosomal degradation.
  • The MOR(TM1) peptide disrupts MOR/DOR interactions and prevents MOR degradation.
  • Systemic administration of MOR(TM1)-TAT enhances morphine analgesia and reduces antinociceptive tolerance in mice.

Conclusions:

  • Preventing MOR/DOR codegradation enhances MOR activity and analgesic efficacy.
  • Disrupting MOR/DOR interactions is a promising strategy for improving opioid therapies.
  • Targeting MOR/DOR dissociation may offer a novel approach to pain management.

More Related Videos

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography09:09

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Published on: September 20, 2016

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding10:13

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Published on: June 9, 2017

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...